Human antibody Clone No.4 can be used as a blocking antibody to treat HBV-related hepatitis disease
Updated time: 2021-05-14 17:03:18
Human antibody Clone No.4 can be used as a blocking antibody to treat HBV-related hepatitis disease
Docket Number
28A-1091029
Announcement Date
2021-05-14
IP Status
USP pending
Abstract
Our study revealed that mAb (clone_No.4) can block X receptors and reverse the suppression of TNF-alpha in dendritic cells by HBV. The mAb (clone_No.4) can also modulate cell surface marker expression in PBMC from CHB patient and can significantly increase cytokine secretion from TLR agonist GS-9620-treated PBMC. We prospect that No.4 has the potential to treat HBV infected diseases.
Technological Advantages
- clone_No.4 is the only Ab available to inhibit HBV-mediated immunosuppression.
Applications of Technology
- New drug for inhibition HBV infection.
- New drug for treatment HBV related hepatitis.
Inventor
Shie-Liang Hsieh, Ming-Ting Huang, Pei-Shan Sung, An-Suei, Yang, Chung-Ming Yu
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Human antibody Clone No.4 can be used as a blocking antibody to treat HBV-related hepatitis disease